Search Results - "LENERT, P" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Nucleic acid sensing receptors in systemic lupus erythematosus: development of novel DNA- and/or RNA-like analogues for treating lupus

Nucleic acid sensing receptors in systemic lupus erythematosus: development of novel DNA- and/or RNA-like analogues for treating lupus

by Lenert, P
Published in Clinical and experimental immunology (01.08.2010)

Get full text

Journal Article

Inhibitory oligodeoxynucleotides − therapeutic promise for systemic autoimmune diseases?

Inhibitory oligodeoxynucleotides − therapeutic promise for systemic autoimmune diseases?

by Lenert, P.
Published in Clinical and experimental immunology (01.04.2005)

Get full text

Journal Article

Engagement of the B cell receptor for antigen differentially affects B cell responses to Toll-like receptor-7 agonists and antagonists in BXSB mice

Engagement of the B cell receptor for antigen differentially affects B cell responses to Toll-like receptor-7 agonists and antagonists in BXSB mice

by Layer, T, Steele, A, Goeken, J.A, Fleenor, S, Lenert, P
Published in Clinical and experimental immunology (01.03.2011)

Get full text

Journal Article

B-cell receptor for antigen modulates B-cell responses to complex TLR9 agonists and antagonists: implications for systemic lupus erythematosus

B-cell receptor for antigen modulates B-cell responses to complex TLR9 agonists and antagonists: implications for systemic lupus erythematosus

by Goeken, JA, Layer, T., Fleenor, S., Laccheo, M., Lenert, P.
Published in Lupus (01.10.2010)

Get full text

Journal Article

Identification of methylated CpG motifs as inhibitors of the immune stimulatory CpG motifs

Identification of methylated CpG motifs as inhibitors of the immune stimulatory CpG motifs

by CHEN, Y, LENERT, P, WEERATNA, R, MCCLUSKIE, M, WU, T, DAVIS, H. L, KRIEG, A. M
Published in Gene therapy (01.07.2001)

Get full text

Journal Article

Targeting Toll-like receptor signaling in plasmacytoid dendritic cells and autoreactive B cells as a therapy for lupus

Targeting Toll-like receptor signaling in plasmacytoid dendritic cells and autoreactive B cells as a therapy for lupus

by Lenert, Petar S
Published in Arthritis research & therapy (01.01.2006)

Get full text

Journal Article

Activation of Marginal Zone B Cells from Lupus Mice with Type A(D) CpG-Oligodeoxynucleotides

Activation of Marginal Zone B Cells from Lupus Mice with Type A(D) CpG-Oligodeoxynucleotides

by Brummel, Rachel, Lenert, Petar
Published in The Journal of immunology (1950) (15.02.2005)

Get full text

Journal Article

Current and emerging treatment options forANCA-associated vasculitis: potential role of belimumab and other BAFF/APRIL targeting agents

Current and emerging treatment options forANCA-associated vasculitis: potential role of belimumab and other BAFF/APRIL targeting agents

by Lenert A, Lenert P
Published in Drug design, development and therapy (01.01.2015)

Get full text

Journal Article

Abnormal thymic maturation and lymphoproliferation in MRL-Fas lpr/lpr mice can be partially reversed by synthetic oligonucleotides: implications for systemic lupus erythematosus and autoimmune lymphoproliferative syndrome

Abnormal thymic maturation and lymphoproliferation in MRL-Fas lpr/lpr mice can be partially reversed by synthetic oligonucleotides: implications for systemic lupus erythematosus and autoimmune lymphoproliferative syndrome

by Ashman, R F, Singh, N, Lenert, P S
Published in Lupus (01.06.2017)

Get full text

Journal Article

Abnormal thymic maturation and lymphoproliferation in MRL-Faslpr/lpr mice can be partially reversed by synthetic oligonucleotides: implications for systemic lupus erythematosus and autoimmune lymphoproliferative syndrome

Abnormal thymic maturation and lymphoproliferation in MRL-Faslpr/lpr mice can be partially reversed by synthetic oligonucleotides: implications for systemic lupus erythematosus and autoimmune lymphoproliferative syndrome

by Ashman, R F, Singh, N, Lenert, P S
Published in Lupus (01.06.2017)

Get full text

Journal Article

Spotlight on blisibimod and its potential in the treatment of systemic lupus erythematosus: evidence to date

Spotlight on blisibimod and its potential in the treatment of systemic lupus erythematosus: evidence to date

by Lenert, Aleksander, Niewold, Timothy B, Lenert, Petar
Published in Drug design, development and therapy (2017)

Get full text

Journal Article

Atezolizumab after Nivolumab-Induced Inflammatory Polyarthritis: Can Anti–PD-L1 Immunotherapy Be Administered after Anti–PD-1–Related Immune Toxicities?

Atezolizumab after Nivolumab-Induced Inflammatory Polyarthritis: Can Anti–PD-L1 Immunotherapy Be Administered after Anti–PD-1–Related Immune Toxicities?

by Swami, Umang, Lenert, Petar, Furqan, Muhammad, Abu Hejleh, Taher, Clamon, Gerald, Zhang, Jun
Published in Journal of thoracic oncology (01.06.2018)

Get full text

Journal Article

REVIEW ARTICLE: Inhibitory oligodeoxynucleotides - therapeutic promise for systemic autoimmune diseases?

REVIEW ARTICLE: Inhibitory oligodeoxynucleotides - therapeutic promise for systemic autoimmune diseases?

by Lenert, P
Published in Clinical and experimental immunology (01.04.2005)

Get full text

Journal Article

Inhibitory oligodeoxynucteotides - therapeutic promise for systemic autoimmune diseases?

Inhibitory oligodeoxynucteotides - therapeutic promise for systemic autoimmune diseases?

by Lenert, P
Published in Clinical and experimental immunology (01.04.2005)

Get full text

Journal Article

TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production

TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production

by Lenert, Petar, Brummel, Rachel, Field, Elizabeth H, Ashman, Robert F
Published in Journal of clinical immunology (01.01.2005)

Get full text

Journal Article

Inhibitory Oligodeoxynucleotide (ODN) Activity in Human B Cells

Inhibitory Oligodeoxynucleotide (ODN) Activity in Human B Cells

by Ashman, R, Goeken, A, Lenert, P
Published in Clinical immunology (Orlando, Fla.) (01.01.2008)

Get full text

Journal Article

Inhibitory oligonucleotides specifically block effects of stimulatory CpG oligonucleotides in B cells

Inhibitory oligonucleotides specifically block effects of stimulatory CpG oligonucleotides in B cells

by Stunz, Laura L., Lenert, Petar, Peckham, David, Yi, Ae‐Kyung, Haxhinasto, Sokol, Chang, Ming, Krieg, Arthur M., Ashman, Robert F.
Published in European journal of immunology (01.05.2002)

Get full text

Journal Article

Inhibitory oligonucleotides block the induction of AP-1 transcription factor by stimulatory CpG oligonucleotides in B cells

Inhibitory oligonucleotides block the induction of AP-1 transcription factor by stimulatory CpG oligonucleotides in B cells

by Lenert, Petar, Yi, Ae-Kyung, Krieg, Arthur M, Stunz, Laura L, Ashman, Robert F
Published in Antisense & nucleic acid drug development (01.01.2003)

Get more information

Journal Article

Structural requirements and applications of inhibitory oligodeoxyribonucleotides

Structural requirements and applications of inhibitory oligodeoxyribonucleotides

by Ashman, Robert F, Lenert, Petar
Published in Immunologic research (01.11.2007)

Get full text

Journal Article

Sequence requirements for oligodeoxyribonucleotide inhibitory activity

Sequence requirements for oligodeoxyribonucleotide inhibitory activity

by Ashman, Robert F., Goeken, J. Adam, Drahos, Jennifer, Lenert, Petar
Published in International immunology (01.04.2005)

Get full text

Journal Article